• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

袖状胃切除术和胃旁路术与非手术治疗的体重结局比较。

Weight Outcomes of Sleeve Gastrectomy and Gastric Bypass Compared to Nonsurgical Treatment.

机构信息

Kaiser Permanente Washington Health Research Institute, Seattle, WA.

Kaiser Permanente Southern California, Pasadena, CA.

出版信息

Ann Surg. 2021 Dec 1;274(6):e1269-e1276. doi: 10.1097/SLA.0000000000003826.

DOI:10.1097/SLA.0000000000003826
PMID:32187033
Abstract

OBJECTIVE

To investigate weight trajectories among patients with severe obesity undergoing sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and nonsurgical treatment.

BACKGROUND

Although bariatric procedures are associated with substantial weight loss, few studies have compared surgical outcomes to nonsurgical treatment, particularly for SG.

METHODS

In this retrospective, matched cohort study, adult patients with body mass index ≥35 kg/m2 who underwent RYGB or SG procedures from January 2005 through September 2015 were matched to 87,965 nonsurgical patients. Hierarchical linear models were used to investigate percent total weight loss (%TWL) and regain at 5 years among RYGB, SG, and nonsurgical patients, and at 10 years for RYGB and nonsurgical patients.

RESULTS

Among 13,900 SG, 17,258 RYGB, and 87,965 nonsurgical patients, the 5-year follow-up rate was 70.9%, 72.0%, and 64.5%, respectively. At 1 year, RYGB patients had 28.4%TWL (95% confidence interval: 28.2, 28.5), SG 23.0%TWL (22.8, 23.2), and nonsurgical patients 0.2%TWL (0.1, 0.4). At 5 years, RYGB had 21.7%TWL (21.5, 22.0), SG 16.0%TWL (15.4, 16.6), and nonsurgical patients 2.2%TWL (2.0, 2.5). After 5 years, 3.7% of RYGB and 10.1% of SG patients had regained weight to within 5% of baseline. At 10 years, RYGB patients had 20.2%TWL (19.3, 21.0) and nonsurgical patients 4.8%TWL (4.0, 5.5).

CONCLUSIONS

In this study, patients with severe obesity who underwent SG and RYGB lost significantly more weight at 5 years than nonsurgical patients. Weight regain was common after surgery but regain to within 5% of baseline was rare.

摘要

目的

研究行袖状胃切除术(SG)、胃旁路术(RYGB)和非手术治疗的重度肥胖患者的体重变化轨迹。

背景

尽管减重手术与显著的体重减轻相关,但很少有研究将手术结果与非手术治疗进行比较,特别是对于 SG。

方法

在这项回顾性、匹配队列研究中,将 2005 年 1 月至 2015 年 9 月期间接受 RYGB 或 SG 手术的 BMI≥35kg/m2 的成年患者与 87965 名非手术患者相匹配。采用分层线性模型,研究 RYGB、SG 和非手术患者在 5 年时的总减重百分比(%TWL)和体重恢复情况,以及 RYGB 和非手术患者在 10 年时的%TWL。

结果

在 13900 名 SG、17258 名 RYGB 和 87965 名非手术患者中,5 年随访率分别为 70.9%、72.0%和 64.5%。术后 1 年,RYGB 患者的体重减轻率为 28.4%(95%置信区间:28.2,28.5),SG 为 23.0%(22.8,23.2),而非手术患者为 0.2%(0.1,0.4)。术后 5 年,RYGB 患者的体重减轻率为 21.7%(21.5,22.0),SG 为 16.0%(15.4,16.6),而非手术患者为 2.2%(2.0,2.5)。术后 5 年后,3.7%的 RYGB 和 10.1%的 SG 患者体重恢复到基线的 5%以内。术后 10 年,RYGB 患者的体重减轻率为 20.2%(19.3,21.0),而非手术患者为 4.8%(4.0,5.5)。

结论

在这项研究中,行 SG 和 RYGB 的重度肥胖患者在 5 年内体重减轻明显多于非手术患者。手术后体重恢复是常见的,但恢复到基线的 5%以内是罕见的。

相似文献

1
Weight Outcomes of Sleeve Gastrectomy and Gastric Bypass Compared to Nonsurgical Treatment.袖状胃切除术和胃旁路术与非手术治疗的体重结局比较。
Ann Surg. 2021 Dec 1;274(6):e1269-e1276. doi: 10.1097/SLA.0000000000003826.
2
Bariatric Surgery and Long-term Durability of Weight Loss.减肥手术与体重减轻的长期持久性
JAMA Surg. 2016 Nov 1;151(11):1046-1055. doi: 10.1001/jamasurg.2016.2317.
3
Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy in Young Adults: a Dutch Registry Study.年轻成年人中Roux-en-Y胃旁路术与袖状胃切除术的比较:一项荷兰登记研究
Obes Surg. 2022 Mar;32(3):763-770. doi: 10.1007/s11695-021-05846-4. Epub 2022 Jan 29.
4
Weight recurrence after Sleeve Gastrectomy versus Roux-en-Y gastric bypass: a propensity score matched nationwide analysis.袖状胃切除术与 Roux-en-Y 胃旁路术后体重复发:全国倾向评分匹配分析。
Surg Endosc. 2023 Jun;37(6):4351-4359. doi: 10.1007/s00464-022-09785-8. Epub 2023 Feb 6.
5
Short-Term Outcomes of Sleeve Gastrectomy plus Jejunojejunal Bypass: a Retrospective Comparative Study with Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Chinese Patients with BMI ≥ 35 kg/m.袖状胃切除术联合空肠空肠旁路术的短期疗效:与中国 BMI≥35kg/m2 的袖状胃切除术和 Roux-en-Y 胃旁路术患者的回顾性对比研究
Obes Surg. 2019 Apr;29(4):1352-1359. doi: 10.1007/s11695-018-03688-1.
6
Comparison of Repeat Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Case of Weight Loss Failure After Sleeve Gastrectomy.比较袖状胃切除术失败后的再次袖状胃切除术与 Roux-en-Y 胃旁路术。
Obes Surg. 2019 Dec;29(12):3919-3927. doi: 10.1007/s11695-019-04123-9.
7
Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy.Roux-en-Y 胃旁路术和袖状胃切除术对体重、生活质量和合并症的 7 年随访轨迹。
Int J Obes (Lond). 2022 Apr;46(4):739-749. doi: 10.1038/s41366-021-01028-5. Epub 2022 Jan 1.
8
Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort.PCORnet 减重研究队列中不同种族和族裔人群中 Roux-en-Y 胃旁路术和袖状胃切除术治疗体重和 2 型糖尿病的安全性和有效性比较。
JAMA Surg. 2022 Oct 1;157(10):897-906. doi: 10.1001/jamasurg.2022.3714.
9
Laparoscopic conversion of sleeve gastrectomy to a biliopancreatic diversion with duodenal switch or a Roux-en-Y gastric bypass due to weight loss failure: our algorithm.因减重失败将腹腔镜袖状胃切除术转换为十二指肠转位的胆胰分流术或 Roux-en-Y 胃旁路术:我们的算法
Surg Obes Relat Dis. 2015 Jan-Feb;11(1):79-85. doi: 10.1016/j.soard.2014.04.012. Epub 2014 Apr 24.
10
Reduction in Long-term Mortality After Sleeve Gastrectomy and Gastric Bypass Compared to Nonsurgical Patients With Severe Obesity.袖状胃切除术和胃旁路术与非手术严重肥胖患者相比,长期死亡率降低。
Ann Surg. 2023 Mar 1;277(3):442-448. doi: 10.1097/SLA.0000000000005155. Epub 2021 Aug 13.

引用本文的文献

1
The Role of Physical Activity in Minimizing Recurrence of Weight Gain Following Metabolic and Bariatric Surgery: Current Evidence and Suggestions for Advancing Future Research.体育活动在降低代谢和减重手术后体重增加复发风险中的作用:当前证据及推进未来研究的建议
Curr Obes Rep. 2025 Aug 21;14(1):66. doi: 10.1007/s13679-025-00658-4.
2
Robust causal inference for point exposures with missing confounders.针对存在混杂因素缺失的点暴露进行稳健的因果推断。
Can J Stat. 2025 Jun;53(2). doi: 10.1002/cjs.11832. Epub 2024 Sep 19.
3
Patient and operative characteristics of readmission and poly-readmission following metabolic surgery: an MBSAQIP analysis (2015-2021).
代谢手术后再入院和多次再入院的患者及手术特征:一项MBSAQIP分析(2015 - 2021年)
Surg Endosc. 2025 May 16. doi: 10.1007/s00464-025-11799-x.
4
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data.用于治疗2型糖尿病和肥胖症的双靶点和三靶点肠道肽激动剂即将问世。临床前和临床数据概述
Curr Obes Rep. 2025 Apr 11;14(1):34. doi: 10.1007/s13679-025-00623-1.
5
Estimating weighted quantile treatment effects with missing outcome data by double sampling.通过双重抽样对缺失结果数据估计加权分位数治疗效果。
Biometrics. 2025 Apr 2;81(2). doi: 10.1093/biomtc/ujaf038.
6
Actual weight loss trajectories after bariatric surgery compared with the SOPHIA prediction tool: An observational comparison study.与SOPHIA预测工具相比,减肥手术后的实际体重减轻轨迹:一项观察性比较研究。
Diabetes Obes Metab. 2025 Apr;27(4):2206-2213. doi: 10.1111/dom.16219. Epub 2025 Jan 30.
7
Identifying At-Risk Populations for Reoperations, Readmissions, and Interventions in MBSAQIP Using a Novel Inpatient Postoperative Care Metric.使用一种新型住院术后护理指标识别MBSAQIP中再次手术、再入院和干预的高危人群。
Obes Surg. 2025 Mar;35(3):915-925. doi: 10.1007/s11695-025-07686-y. Epub 2025 Jan 30.
8
Efficacy of anti-obesity medication (AOM) and endoscopic gastric remodeling (EGR): Analysis of combination therapy with optimal timing and agents.抗肥胖药物(AOM)与内镜下胃重塑(EGR)的疗效:最佳时机与药物联合治疗分析
Endosc Int Open. 2024 Dec 17;12(12):E1458-E1464. doi: 10.1055/a-2463-9784. eCollection 2024 Dec.
9
Double Sampling for Informatively Missing Data in Electronic Health Record-Based Comparative Effectiveness Research.基于电子健康记录的比较效果研究中信息性缺失数据的双重抽样
Stat Med. 2024 Dec 30;43(30):6086-6098. doi: 10.1002/sim.10298. Epub 2024 Dec 5.
10
Postprandial hypoglycemia as a complication of bariatric and metabolic surgery: a comprehensive review of literature.餐后低血糖作为减重及代谢手术的并发症:文献综述
Front Surg. 2024 Nov 1;11:1449012. doi: 10.3389/fsurg.2024.1449012. eCollection 2024.